ARCHIVES

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

Southwest Oncology Group Becomes “SWOG”

April 8, 2011

Sharfstein To Leave FDA

January 7, 2011

Concepts Approved for Primary Care, Worker Health, Black Interventions

May 17, 1985

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008

In Brief: BMS Chemistry Awards to Honor Fu, Wood; Groshow Joins NCI; Bowman Moves to TJU

January 15, 1999

Other Contract Concepts Approved By DCE Board

March 10, 1989